223 related articles for article (PubMed ID: 26034157)
1. Evaluation of the Satisfaction with Appearance Scale and Its Short Form in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life Study.
Mills SD; Fox RS; Merz EL; Clements PJ; Kafaja S; Malcarne VL; Furst DE; Khanna D
J Rheumatol; 2015 Sep; 42(9):1624-30. PubMed ID: 26034157
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of the brief-satisfaction with appearance scale for systemic sclerosis.
Jewett LR; Hudson M; Haythornthwaite JA; Heinberg L; Wigley FM; Baron M; Thombs BD;
Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1779-86. PubMed ID: 20665750
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of the Body Concealment Scale for Scleroderma.
Jewett LR; Malcarne VL; Kwakkenbos L; Harcourt D; Rumsey N; Körner A; Steele RJ; Hudson M; Baron M; Haythornthwaite JA; Heinberg L; Wigley FM; Thombs BD;
Arthritis Care Res (Hoboken); 2016 Aug; 68(8):1158-65. PubMed ID: 26663624
[TBL] [Abstract][Full Text] [Related]
4. Assessment of English-French differential item functioning of the Satisfaction with Appearance Scale (SWAP) in systemic sclerosis.
Jewett LR; Kwakkenbos L; Hudson M; Baron M; Thombs BD;
Body Image; 2017 Sep; 22():97-102. PubMed ID: 28711486
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Body Concealment Scale for Scleroderma (BCSS): Replication in the Scleroderma Patient-centered Intervention Network (SPIN) Cohort.
Jewett LR; Kwakkenbos L; Carrier ME; Malcarne VL; Harcourt D; Rumsey N; Mayes MD; Assassi S; Körner A; Fox RS; Gholizadeh S; Mills SD; Fortune C; Portales A; Thombs BD;
Body Image; 2017 Mar; 20():99-106. PubMed ID: 28068643
[TBL] [Abstract][Full Text] [Related]
6. Structural Validity of the Rheumatology Attitudes Index in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life Study.
Gholizadeh S; Mills SD; Fox RS; Merz EL; Roesch SC; Clements PJ; Kafaja S; Furst DE; Khanna D; Malcarne VL
J Rheumatol; 2017 Jun; 44(6):795-798. PubMed ID: 28412704
[TBL] [Abstract][Full Text] [Related]
7. Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study.
Fox RS; Kwakkenbos L; Carrier ME; Mills SD; Gholizadeh S; Jewett LR; Roesch SC; Merz EL; Assassi S; Furst DE; Gottesman K; Mayes MD; Thombs BD; Malcarne VL;
Arthritis Care Res (Hoboken); 2018 Nov; 70(11):1646-1652. PubMed ID: 29409146
[TBL] [Abstract][Full Text] [Related]
8. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.
Rannou F; Poiraudeau S; Berezné A; Baubet T; Le-Guern V; Cabane J; Guillevin L; Revel M; Fermanian J; Mouthon L
Arthritis Rheum; 2007 Feb; 57(1):94-102. PubMed ID: 17266096
[TBL] [Abstract][Full Text] [Related]
9. Satisfaction With Appearance Scale-SWAP: Adaptation and validation for Brazilian burn victims.
Caltran MP; Freitas NO; Dantas RA; Farina JA; Rossi LA
Burns; 2016 Sep; 42(6):1331-9. PubMed ID: 27143340
[TBL] [Abstract][Full Text] [Related]
10. The cultural adaptation and validation of a Swedish version of the satisfaction with appearance scale (SWAP-Swe).
Dahl O; Wickman M; Wengström Y
Burns; 2014 Jun; 40(4):598-605. PubMed ID: 24080124
[TBL] [Abstract][Full Text] [Related]
11. Translation, cross-cultural adaptation, and validation of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument (SCTC GIT) 2.0 into Dutch.
Meijs J; Pors D; Vliet Vlieland TP; Huizinga TW; Schouffoer AA
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-41-8. PubMed ID: 24984228
[TBL] [Abstract][Full Text] [Related]
12. Shortening patient-reported outcome measures through optimal test assembly: application to the Social Appearance Anxiety Scale in the Scleroderma Patient-centered Intervention Network Cohort.
Harel D; Mills SD; Kwakkenbos L; Carrier ME; Nielsen K; Portales A; Bartlett SJ; Malcarne VL; Thombs BD;
BMJ Open; 2019 Feb; 9(2):e024010. PubMed ID: 30798308
[TBL] [Abstract][Full Text] [Related]
13. Validation of the UCLA Scleroderma Clinica Trial Gastrointestinal Tract Instrument version 2.0 for systemic sclerosis.
Baron M; Hudson M; Steele R; Lo E;
J Rheumatol; 2011 Sep; 38(9):1925-30. PubMed ID: 21724704
[TBL] [Abstract][Full Text] [Related]
14. Reliability and validity of the center for epidemiologic studies depression scale in patients with systemic sclerosis.
Thombs BD; Hudson M; Schieir O; Taillefer SS; Baron M;
Arthritis Rheum; 2008 Mar; 59(3):438-43. PubMed ID: 18311754
[TBL] [Abstract][Full Text] [Related]
15. The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society.
Taş YM; Derviş Hakim G; Keskinoğlu P; Kenar G; Yarkan H; Zengin B; Can G; Önen F; Akkoç N; Birlik M; Akarsu M
Turk J Gastroenterol; 2019 Mar; 30(3):234-241. PubMed ID: 30541712
[TBL] [Abstract][Full Text] [Related]
16. Factor structure and convergent validity of the Derriford Appearance Scale-24 using standard scoring versus treating 'not applicable' responses as missing data: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study.
Merz EL; Kwakkenbos L; Carrier ME; Gholizadeh S; Mills SD; Fox RS; Jewett LR; Williamson H; Harcourt D; Assassi S; Furst DE; Gottesman K; Mayes MD; Moss TP; Thombs BD; Malcarne VL;
BMJ Open; 2018 Mar; 8(3):e018641. PubMed ID: 29511009
[TBL] [Abstract][Full Text] [Related]
17. Validation of the Social Appearance Anxiety Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study.
Mills SD; Kwakkenbos L; Carrier ME; Gholizadeh S; Fox RS; Jewett LR; Gottesman K; Roesch SC; Thombs BD; Malcarne VL;
Arthritis Care Res (Hoboken); 2018 Oct; 70(10):1557-1562. PubMed ID: 29342510
[TBL] [Abstract][Full Text] [Related]
18. The validity and reliability of the Swedish version of the Satisfaction with appearance scale for individuals with systemic sclerosis.
Mattsson M; Hesselstrand R; Gunnarsson K; Dyrsmeds E; Holmner M; Nordin A; Boström C
J Scleroderma Relat Disord; 2023 Feb; 8(1):53-63. PubMed ID: 36743814
[TBL] [Abstract][Full Text] [Related]
19. Assessing body image in patients with systemic sclerosis (scleroderma): validation of the adapted Satisfaction with Appearance Scale.
Heinberg LJ; Kudel I; White B; Kwan A; Medley K; Wigley F; Haythornthwaite J
Body Image; 2007 Mar; 4(1):79-86. PubMed ID: 18089254
[TBL] [Abstract][Full Text] [Related]
20. Validity and correlates of the Brief Satisfaction With Appearance Scale for patients with limited and diffuse systemic sclerosis: Analysis from the University of California, Los Angeles Scleroderma Quality of Life Study.
Fox RS; Mills SD; Gholizadeh S; Merz EL; Roesch SC; Clements PJ; Kafaja S; Khanna D; Furst DE; Malcarne VL
J Scleroderma Relat Disord; 2020 Jun; 5(2):143-151. PubMed ID: 35382027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
